American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 613.e1-613.e8, December 2009

Cardiovascular responses to maternal betamethasone administration in the intrauterine growth–restricted ovine fetus

  • Suzanne L. Miller, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia
    • Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, VIC, Australia
    • Corresponding Author InformationReprints: Suzanne L. Miller, PhD, Department of Obstetrics and Gynaecology, Monash University, 5th Floor, Monash Medical Centre, Clayton 3168, VIC, Australia
  • ,
  • Veena G. Supramaniam, PhD

      Affiliations

    • Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, VIC, Australia
  • ,
  • Graham Jenkin, PhD

      Affiliations

    • Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, VIC, Australia
  • ,
  • David W. Walker, PhD

      Affiliations

    • Department of Physiology, Monash University, Clayton, VIC, Australia
  • ,
  • Euan M. Wallace, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia

Received 11 March 2009; received in revised form 13 May 2009; accepted 14 July 2009. published online 23 September 2009.

Objective

The objective was to characterize the effect of glucocorticoid treatment on fetal organ blood flow and regional cerebral blood flow in normally grown fetuses and fetuses with intrauterine fetal growth restriction (IUGR).

Study Design

Studies were undertaken in both control and IUGR fetal sheep; growth restriction was induced by ligation of 1 umbilical artery. Fetuses received colored microspheres for organ blood flow calculations before and after 2 maternal betamethasone injections (BM1 and BM2).

Results

Following BM1, cardiac output was significantly decreased in the control fetuses and blood flow to the heart and placenta was unchanged, whereas total cerebral blood flow was significantly decreased (P < .001), consistent with cerebral vasoconstriction. In the fetuses with IUGR, the cardiac output was significantly increased at +33 hours relative to BM1, and blood flow was increased in all organs; notably, there was a 2-fold increase in cerebral blood flow (P = .03).

Conclusion

The cardiovascular response of the fetus with IUGR to glucocorticoids is profoundly different from the control fetuses, which may induce both short- and long-term injury.

Key words: cardiac output, glucocorticoids, intrauterine growth restriction, regional blood flow

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a project Grant from the National Health and Medical Research Council of Australia (S.L.M., G.J., D.W.W., and E.M.W.) and a Glyn White Research Fellowship through The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (S.L.M.).

 Cite this article as: Miller SL, Supramaniam VG, Jenkin G, et al. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth–restricted ovine fetus. Am J Obstet Gynecol 2009;201:613.e1-8.

PII: S0002-9378(09)00815-1

doi:10.1016/j.ajog.2009.07.028

American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 613.e1-613.e8, December 2009